Mattias Bernow

Cellcolabs AB is a company that aims to accelerate stem cell research and make future treatments available to everyone. The company is based in Solna, Sweden. The Swedish company provides high-quality stem cells at competitive prices for use in research and treatments. The company sponsor and supports clinical trials and offer GMP certified bone-marrow derived MSC for clinical use and GLP cells for preclinical use. It was founded in 2021, and the CEO is Mattias Bernow.

Cellcolabs AB is a company that aims to accelerate stem cell research and make future treatments available to everyone. The company is based in Solna, Sweden. The Swedish company provides high-quality stem cells at competitive prices for use in research and treatments. The company sponsor and supports clinical trials and offer GMP certified bone-marrow derived MSC for clinical use and GLP cells for preclinical use. It was founded in 2021, and the CEO is Mattias Bernow.

Cellcolabs AB is a company that aims to accelerate stem cell research and make future treatments available to everyone. The company is based in Solna, Sweden. The Swedish company provides high-quality stem cells at competitive prices for use in research and treatments. The company sponsor and supports clinical trials and offer GMP certified bone-marrow derived MSC for clinical use and GLP cells for preclinical use. It was founded in 2021, and the CEO is Mattias Bernow.

Cellcolabs AB is a company that aims to accelerate stem cell research and make future treatments available to everyone. The company is based in Solna, Sweden. The Swedish company provides high-quality stem cells at competitive prices for use in research and treatments. The company sponsor and supports clinical trials and offer GMP certified bone-marrow derived MSC for clinical use and GLP cells for preclinical use. It was founded in 2021, and the CEO is Mattias Bernow.

Cellcolabs AB is a company that aims to accelerate stem cell research and make future treatments available to everyone. The company is based in Solna, Sweden. The Swedish company provides high-quality stem cells at competitive prices for use in research and treatments. The company sponsor and supports clinical trials and offer GMP certified bone-marrow derived MSC for clinical use and GLP cells for preclinical use. It was founded in 2021, and the CEO is Mattias Bernow.